Salivary adenoid cystic carcinoma (SACC) can recur after removal of the primary tumor and treatment, where they can keep no clinical symptoms and dormant state for 10–15 years. NR2F1 has been demonstrated to regulate the tumor cell dormancy in various malignant tumors and has a potential impact on recurrence and metastasis of carcinoma. | NR2F1 contributes to cancer cell dormancy invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12 CXCR4 pathway
